Total Pageviews

Monday, March 11, 2013

Seating Arrangement - Decentralized Exams

Dear staff and students,
The terminal exams from 12/03/2013 will be held in decentralized pattern. Students can go to their usual class rooms at 8.30 am. Our staff members will conduct invigilation as per day order time table. All the classes will be conducted as per time table after exam hours. For any clarification pls contact HOD.

Yours sincerely,
Ramesh.B

Tuesday, March 5, 2013

Terminal time table

Terminal Examination Time table :
               

I B.SC CLA2B TAMIL 11/03/2013
I B.SC CLG2B SANSKRIT 11/03/2013
I B.SC CLZ2J ENGLISH 12/03/2013
I B.SC SAC2B MOLECULAR DEVELOPMENTAL BIOLOGY 13/3/2013
I B.SC SBADE CHEMISTRY 14/3/2013
II B.SC CLA4D TAMIL 11/03/2013
II B.SC CLG4D SANSKRIT 11/03/2013
II B.SC CLZ4D ENGLISH 12/03/2013
II B.SC SAC4A PLANT BIOTECHNOLOGY 13/3/2013
II B.SC SBACB BIOPHYSICS AND BIO STATISTICS 14/3/2013
III B.SC SAC6A GENETIC ENGINEERING 11/03/2013
III B.SC SAC6B BIOPROCESS TECHNOLOGY 12/03/2013
III B.SC SEC6A MICROBIAL BIOTECHNOLOGY 13/3/2013
III B.SC SEC6B ENVIRONMENTAL BIOTECHNOLOGY 14/3/2013
I M.SC MDK2A MICROBIOLOGY 11/03/2013
I M.SC MDK2B PLANT AND ANIMAL BIOTECHNOLOGY 12/03/2013
I M.SC MDK2C GENETIC ENGINEERING 13/3/2013
I M.SC MDKAE PHARMACEUTICAL BIOTECHNOLOGY 14/3/2013
I M.SC MDKAG ENVIRONMENTAL BIOTECHNOLOGY 15/3/2013
II M.SC MCK4A ENVIRONMENTAL BIOTECHNOLOGY AND NANO BIOTECHNOLOGY 11/03/2013
II M.SC MCKAH BIOETHICS, HUMAN RIGHTS AND SOCIAL ISSUES 12/03/2013
II M.SC MCKAJ ANIMAL BIOTECHNOLOGY 13/3/2013

Friday, March 1, 2013

RNA Fragments May Yield Rapid, Accurate Cancer Diagnosis

Tumor cells shed microvesicles containing proteins and RNA fragments, called exosomes, into cerebral spinal fluid, blood, and urine. Within these exosomes is genetic information that can be analyzed to determine the cancer’s molecular composition and state of progression.Researchers at Massachusetts General Hospital discovered that exosomes preserve the genetic information of their parent cells exosomes have not seen widespread clinical testing as a means of cancer diagnosis until now.We have never really been able to detect the genetic components of a tumor by blood or spinal fluid,” says Harvard University neurologist Fred Hochberg. 
Exosome diagnostic tests could potentially detect and monitor the progression of a wide variety of cancers. When treating other forms of cancer, surgeons are able to biopsy tumors to diagnose and monitor the state of the disease. For brain cancers like glioma, however, multiple biopsies can be life threatening.Magnetic Resonance Imaging (MRI) is a useful tool, tumors only show up on imaging scans once they are at least one millimeter in diameter and comprise about 100,000 tumor cells.By that time, it may be too late for an early intervention. On the flip side, MRIs can also yield false positives. Exosomes may be a reliable method of screening for prostate cancer as well. A PSA test is currently the most common, noninvasive means to screen for prostate cancer in the U.S. PSA testing measures for elevated levels of prostate-specific antigen, a protein produced by the prostate gland that is used to liquefy semen in men.The higher a man’s PSA level, the more likely it is that he has prostate cancer, says James McKiernan, director of urologic oncology at Columbia University Medical Center. There are additional reasons, however, for high PSA levels-and some men with prostate cancer do not always have elevated PSA, he added.“Exosomes could be very much [more] cancer specific. PSA might give you one specific biomarker for cancer identification, but exosomes can give you an entire disease specific profile so you would know whether or not it is a form of prostate cancer that necessitates treatment.”Researchers at Exosome have developed a diagnostic kit for prostate cancer with a diagnostic accuracy of around 75 percent-a rate comparable with that of actually taking a tissue biopsy, says Wayne Comper, a renal physiologist and chief science officer at Exosome. He says the first diagnostic kit could be available commercially by the end of 2013.


The top ten biotech companies of India


-->
  1. Biocon
Biocon is the first and presently the leading biotech company in India. Initially it brought in revenues by manufacturing enzymes. But it has gradually become more research oriented with the goal of introducing new drugs to the market. Its manufacturing capabilities include microbial and mammalian cell culture fermentation, synthetic chemistry and therapeutic drugs for the treatment of cancer, autoimmune and metabolic diseases.
  1. Serum Institute of India
Serum Institute of India, Indian Immunologicals and Bharat Biotech specialize in the production of vaccines. Serum Institute of India is the world’s largest producer of measles and DTP vaccines.
  1. Panacea Biotec
Panacea Biotec has recently set up a plant in Himachal Pradesh, India, for production of bacterial and viral vaccines.
  1. Nicholas Piramal
  2. Wockhadrt Limited
Wockhardt is a biopharma powerhouse with 11 world class manufacturing plants in India.
  1. GlaxoSmithKline
  2. Bharat Serum
  3. Krebs Biochemicals and Industries Limited
  4. Zydus Cadila
  5. Indian Immunologicals
  6. Shantha Biotechnics
Shantha Biotechnics is located in Hyderabad and its products include Hepatitis B vaccine, Streptokinase drug and Interferon alpha-2b.
  1.  Biological E
  2. Mahyco Monsanto
MAHYCO Monsanto has released a number of Bt cotton hybrids, which have been approved for commercial cultivation. The significant reduction in the use of pesticides and higher and better quality yields will result in increased incomes to farmers. Genetically modified field crops like rice, mustard, groundnut, maize, tubers like potato, vegetables like tomato, cabbage, okra, etc.,
  1. Bharat Biotech
  2.  Ranbaxy   
  3. Novozymes